These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 17190527

  • 1. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L, Cazard F.
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [Abstract] [Full Text] [Related]

  • 3. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
    Herceg M, Muzinić L, Jukić V.
    Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
    [Abstract] [Full Text] [Related]

  • 4. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E, Higgins M, Hammer B, Stephenson P.
    BMC Psychiatry; 2020 Jun 05; 20(1):279. PubMed ID: 32503471
    [Abstract] [Full Text] [Related]

  • 5. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA, Kerwin RW.
    J Clin Psychiatry; 2006 May 05; 67(5):756-60. PubMed ID: 16841625
    [Abstract] [Full Text] [Related]

  • 6. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct 05; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 7. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov 05; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 8. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U, Sanchez P, Hernandez R, Elizagarate E.
    J Clin Psychiatry; 2011 Dec 05; 72(12):1659. PubMed ID: 22244024
    [No Abstract] [Full Text] [Related]

  • 9. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar 05; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 10. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
    Esposito D.
    J Clin Psychiatry; 2007 Apr 05; 68(4):635; author reply 635. PubMed ID: 17474825
    [No Abstract] [Full Text] [Related]

  • 11. Severe neutropenia unrelated to clozapine in patients receiving clozapine.
    Taylor D, Vallianatou K, Gandhi S, Casetta C, Howes O, MacCabe J.
    J Psychopharmacol; 2024 Jul 05; 38(7):624-635. PubMed ID: 39041349
    [Abstract] [Full Text] [Related]

  • 12. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun 05; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 13. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R, Subhalakshmi TP, Kuruvilla A, Jacob KS.
    J Postgrad Med; 2013 Jun 05; 59(1):54-5. PubMed ID: 23525060
    [Abstract] [Full Text] [Related]

  • 14. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 15. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.
    Br J Psychiatry; 1996 Oct 12; 169(4):483-8. PubMed ID: 8894200
    [Abstract] [Full Text] [Related]

  • 16. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P, Slater S, Measham T, Koch M, Wiviott G.
    Int Clin Psychopharmacol; 1998 May 12; 13(3):137-40. PubMed ID: 9690982
    [Abstract] [Full Text] [Related]

  • 17. Sudden late onset of clozapine-induced agranulocytosis.
    Patel NC, Dorson PG, Bettinger TL.
    Ann Pharmacother; 2002 Jun 12; 36(6):1012-5. PubMed ID: 12022904
    [Abstract] [Full Text] [Related]

  • 18. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia.
    Alisky JM.
    Med Hypotheses; 2012 Oct 12; 79(4):497-9. PubMed ID: 22818272
    [Abstract] [Full Text] [Related]

  • 19. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J, Malik S, Krivoy A, Whiskey E, Taylor DM, Gaughran FP, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Oct 12; 37(5):600-604. PubMed ID: 28817489
    [Abstract] [Full Text] [Related]

  • 20. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F, Tsang P, Barr AM.
    Am J Psychiatry; 2013 Oct 12; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.